Clinical ResearchIntervention in Valve Disease2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis
Intervention in Valve Disease
Under an Elsevier user license
open archive
Key Words
aortic valve stenosis
long-term follow-up
transcatheter aortic valve implantation
Abbreviations and Acronyms
AR
aortic regurgitation
EOA
effective orifice area
EuroSCORE
European System for Cardiac Operative Risk Evaluation
HRinop
high-risk inoperable
HRop
high-risk operable
MACCE
major adverse cardiovascular and cerebrovascular event(s)
MR
moderate risk
NYHA
New York Heart Association
TAVI
transcatheter aortic valve implantation
TIA
transient ischemic attack
Cited by (0)
Drs. Buellesfeld, Gerckens, Schuler, Bonan, Kovac, Serruys, Labinaz, den Heijer, Windecker, and Grube are consultants and/or proctors for Medtronic. Dr. Kovac is a consultant to St. Jude. Dr. Mullen is a proctor for Edwards Lifesciences. Dr. Windecker receives lecture and consultant fees from Abbott, Biosensors, Boston Scientific, Cordis, Edwards Lifesciences, and Medtronic. All other authors have reported that they have no relationships to disclose. Dr. Buellesfeld and Gerckens contributed equally to this work.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.